Anti-NDUFA11 monoclonal antibody

Pre-made anti-NDUFA11 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NDUFA11/NDUFA11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1253-Ab-1/ GM-Tg-hg-IP1253-Ab-2Anti-Human NDUFA11 monoclonal antibodyHuman
GM-Tg-rg-IP1253-Ab-1/ GM-Tg-rg-IP1253-Ab-2Anti-Rat NDUFA11 monoclonal antibodyRat
GM-Tg-mg-IP1253-Ab-1/ GM-Tg-mg-IP1253-Ab-2Anti-Mouse NDUFA11 monoclonal antibodyMouse
GM-Tg-cynog-IP1253-Ab-1/ GM-Tg-cynog-IP1253-Ab-2Anti-Cynomolgus/ Rhesus macaque NDUFA11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1253-Ab-1/ GM-Tg-felg-IP1253-Ab-2Anti-Feline NDUFA11 monoclonal antibodyFeline
GM-Tg-cang-IP1253-Ab-1/ GM-Tg-cang-IP1253-Ab-2Anti-Canine NDUFA11 monoclonal antibodyCanine
GM-Tg-bovg-IP1253-Ab-1/ GM-Tg-bovg-IP1253-Ab-2Anti-Bovine NDUFA11 monoclonal antibodyBovine
GM-Tg-equg-IP1253-Ab-1/ GM-Tg-equg-IP1253-Ab-2Anti-Equine NDUFA11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1253-Ab-1/ GM-Tg-hg-IP1253-Ab-2; GM-Tg-rg-IP1253-Ab-1/ GM-Tg-rg-IP1253-Ab-2;
GM-Tg-mg-IP1253-Ab-1/ GM-Tg-mg-IP1253-Ab-2; GM-Tg-cynog-IP1253-Ab-1/ GM-Tg-cynog-IP1253-Ab-2;
GM-Tg-felg-IP1253-Ab-1/ GM-Tg-felg-IP1253-Ab-2; GM-Tg-cang-IP1253-Ab-1/ GM-Tg-cang-IP1253-Ab-2;
GM-Tg-bovg-IP1253-Ab-1/ GM-Tg-bovg-IP1253-Ab-2; GM-Tg-equg-IP1253-Ab-1/ GM-Tg-equg-IP1253-Ab-2
Products NameAnti-NDUFA11 monoclonal antibody
Formatmab
Target NameNDUFA11
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NDUFA11 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1253-Ag-1Recombinant multi-species NDUAB/ NDUFA11/ B14.7 protein


    Target information

    Target IDGM-IP1253
    Target NameNDUFA11
    Gene ID126328,69875,301123,697843,476735,101093917,326346,100147033
    Gene Symbol and Synonyms2010012C24Rik,B14.7,CI-B14.7,MC1DN14,NDUFA11
    Uniprot AccessionQ86Y39,Q80W89,Q8HXG6
    Uniprot Entry NameNDUAB_HUMAN,NDUAB_RAT,NDUAB_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174886
    Target ClassificationN/A

    The target: NDUFA11, gene name: NDUFA11, also named as B14.7, CI-B14.7. This gene encodes a subunit of the membrane-bound mitochondrial complex I. Complex I is composed of numerous subunits and functions as the NADH-ubiquinol reductase of the mitochondrial electron transport chain. Mutations in this gene are associated with severe mitochondrial complex I deficiency. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.